Wilmington-based DowDupont Inc. is among a group of companies that see human breast milk as the next big health supplement for adults, potentially presenting a $1 billion market.
According to a new report in Bloomberg, DowDupont — which will spin out DuPont into a separate company on June 1 — is investing $40 million to expand production of a synthetic version of human milk oligosaccharide, (HMO) a sugar found in breast milk that's indigestible in the stomach and valued for its ability to reach…
